Hybrid Coronary Artery Revascularization—Review and Update 2007
AbstractHybrid coronary revascularization is a combination of minimally invasive coronary artery bypass grafting and percutaneous coronary intervention in patients with multivessel coronary artery disease. The concept is now 10 years old. Implementation was slow, but major developments have taken place. The surgical part of the procedure can be performed in a totally endoscopic fashion instead of by a mini-incision approach and catheter-based intervention includes the use of drug-eluting stents. Whereas during early development staged approaches were taken, simultaneous interventions have become feasible. Hybrid procedures are an attractive option for high-risk patients or for patients who seek a less traumatic revascularization option.
Angelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. 1996. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet34:757-8.nBonatti J, Danzmayr M, Schachner T, Friedrich G. 2003. Intraoperative angiography for quality control in MIDCAB and OPCAB. Eur J Cardiothorac Surg24:647-9.nBonatti J, Schachner T, Bonaros N, et al. 2005. Robotic totally endo-scopic coronary artery bypass and catheter-based intervention in one session. Heart Surg Forum8:E284-6.nBonatti J, Schachner T, Bonaros N, et al. 2007. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. Cardiology [in press].nBoylan MJ, Lytle BW, Loop FD, et al. 1994. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J Thorac Cardiovasc Surg107:657-62.nBrinster DR, Byrne M, Rogers CD, et al. 2006. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach"). Am J Cardiol98:1501-3.nCamenzind E. 2006. Treatment of in-stent restenosis—back to the future? N Engl J Med355:2149-51.nCamenzind E, Steg PG, Wijns W. 2007. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause of concern. Circulation115:1440-55.nCisowski M, Morawski W, Drzewiecki J, et al. 2002. Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg22:261-5.nDogan S, Aybek T, Andressen E, et al. 2002. Totally endoscopic coronary artery bypass grafting on cardiopulmonary bypass with robotically enhanced telemanipulation: report of forty-five cases. J Thorac Cardiovasc Surg123:1125-31.nFajadet J, Morice MC, Bode C, et al. 2005. Maintenance of long-term clinical benefit with sirolimus eluting stents. Circulation111:1040-44.nFalk V, Diegeler A, Walther T, et al. 2000. Total endoscopic computer enhanced coronary artery bypass grafting. Eur J Cardiothorac Surg17:38-45.nFriedrich GJ, Bonatti J, Dapunt OE. 1997. Preliminary experience with minimally invasive coronary-artery bypass surgery combined with coronary angioplasty. N Engl J Med336:1454-5.nFriedrich GJ, Jonetzko P, Bonaros N, et al. 2005. Hybrid coronary artery revascularization: logistics and program development. Heart Surg Forum8:E258-61.nGoldstein JA, Safian RD, Aliabadi D, et al. 1998. Intraoperative angiog-raphy to assess graft patency after minimally invasive coronary bypass. Ann Thorac Surg66:1978-82.nHirshfeld JW Jr, Schwartz JS, Jugo R, et al. 1991. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators. J Am Coll Cardiol18:647-56.nIzzat MB, Khaw KS, Atassi W, Yim AP, Wan S, El-Zufari MH. 1999. Routine intraoperative angiography improves the early patency of coronary grafts performed on the beating heart. Chest115:987-90.nKatz MR, Van Praet F, de Cannière D, et al. 2006. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation114(suppl I): I-473-6.nKappert U, Cichon R, Schneider J, et al. 2000. Robotic coronary artery surgery—the evolution of a new minimally invasive approach in coronary artery surgery. Thorac Cardiovasc Surg48:193-7.nKiaii B, McClure RS, Kostuk WJ, et al. 2005. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest128:4046-8.nLagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L. 2007. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med356:1009-19.nMack MJ, Brown DL, Sankaran A. 1997. Minimally invasive coronary bypass for protected left main coronary stenosis angioplasty. Ann Thorac Surg64:545-6.nMack MJ, Magovern JA, Acuff TA, et al. 1999. Results of graft patency by immediate angiography in minimally invasive coronary artery surgery. Ann Thorac Surg68:383-9.nMoses JW, Leon MB, Popma JJ, et al; SIRIUS Investigators. 2003. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med349:1315-23.nNordmann AJ, Briel M, Bucher HC. 2006. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J27:2784-814.nOvrum E, Tangen G, Am Holen E. 1997. Facing the era of minimally invasive coronary grafting: current results of conventional bypass grafting for single-vessel disease. Ann Thorac Surg66:1076-81.nRiess FC, Schofer J, Kremer P, et al. 1998. Beating heart operations including hybrid revascularization: initial experiences. Ann Thorac Surg66:1076-81.nSchachner T, Feuchtner G, Bonatti J, et al. 2007. Evaluation of robotic coronary surgery by intraoperative graft angiography in combination with postoperative multislice computed tomography. Ann Thorac Surg [in press].nSerruys PW, Lemos PA, van Hout BA, on behalf of the ARTS II steering Committee and Investigators. 2004. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart90:995-8.nStahl KD, Boyd WD, Vassiliades TA, Karamanoukian HL. 2002. Hybrid robotic coronary artery surgery and angioplasty in multivessel coronary artery disease. Ann Thorac Surg74:S1358-62.nStone GW, Moses JW, Ellis SG, et al. 2007. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med356: 998-1008.nTatoulis J, Buxton BF, Fuller JA. 2004. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg77:93-101.nTsuchida K, Serruys PW, Bruining N, et al. 2007. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. Am J Cardiol99:607-15.nUs M, Basaran M, Yilmaz M, et al. 2006. Hybrid coronary revascularization in high-risk patients. Tex Heart Inst J33:458-62.nWittwer T, Cremer J, Klima U, Wahlers T, Haverich A. 1999. Myocardial "hybrid" revascularization: intermediate results of an alternative approach to multivessel coronary artery disease. J Thorac Cardiovasc Surg118:766-7.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).